Fetal cord plasma herpesviruses and preeclampsia: an observational cohort study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 06 2024
Historique:
received: 03 03 2024
accepted: 19 06 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 25 6 2024
Statut: epublish

Résumé

A previous study suggested that fetal inheritance of chromosomally integrated human herpesvirus 6 (ici-HHV6) is associated with the hypertensive pregnancy disorder preeclampsia (PE). We aimed to study this question utilizing cord plasma samples (n = 1276) of the Finnish Genetics of Preeclampsia Consortium (FINNPEC) cohort: 539 from a pregnancy with PE and 737 without. We studied these samples and 30 placentas from PE pregnancies by a multiplex qPCR for the DNAs of all nine human herpesviruses. To assess the population prevalence of iciHHV-6, we studied whole-genome sequencing data from blood-derived DNA of 3421 biobank subjects. Any herpes viral DNA was detected in only two (0.37%) PE and one (0.14%) control sample (OR 2.74, 95% CI 0.25-30.4). One PE sample contained iciHHV-6B and another HHV-7 DNA. The control's DNA was of iciHHV-6B; the fetus having growth restriction and preterm birth without PE diagnosis. Placentas showed no herpesviruses. In the biobank data, 3 of 3421 subjects (0.08%) had low level HHV-6B but no iciHHV-6. While iciHHV-6 proved extremely rare, both fetuses with iciHHV-6B were growth-restricted, preterm, and from a pregnancy with maternal hypertension. Our findings suggest that human herpesviruses are not a significant cause of PE, whereas iciHHV-6 may pose some fetal risk.

Identifiants

pubmed: 38918446
doi: 10.1038/s41598-024-65386-6
pii: 10.1038/s41598-024-65386-6
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

14605

Subventions

Organisme : Academy of Finland
ID : 121196, 134957 and 278941
Organisme : Knut och Alice Wallenbergs Stiftelse
ID : KAW 2015.0096

Informations de copyright

© 2024. The Author(s).

Références

Rana, S., Lemoine, E., Granger, J. P. & Karumanchi, S. A. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res. 124(7), 1094–1112 (2019).
doi: 10.1161/CIRCRESAHA.118.313276 pubmed: 30920918
WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia. WHO Library Cataloguing-in-Publication Data; 2011.
Osungbade, K. O. & Ige, O. K. Public health perspectives of preeclampsia in developing countries: Implication for health system strengthening. J. Pregnancy. 2011, 481095 (2011).
doi: 10.1155/2011/481095 pubmed: 21547090 pmcid: 3087154
Magee, L. A. et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 27, 148–169 (2022).
doi: 10.1016/j.preghy.2021.09.008 pubmed: 35066406
Fisher, S. J. Why is placentation abnormal in preeclampsia?. Am. J. Obstet. Gynecol. 213(4 Suppl), S115–S122 (2015).
doi: 10.1016/j.ajog.2015.08.042 pubmed: 26428489 pmcid: 4592742
Redman, C. W., Sacks, G. P. & Sargent, I. L. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180(2 Pt 1), 499–506 (1999).
doi: 10.1016/S0002-9378(99)70239-5 pubmed: 9988826
Boeldt, D. S. & Bird, I. M. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J. Endocrinol. 232(1), R27–R44 (2017).
doi: 10.1530/JOE-16-0340 pubmed: 27729465
Liong, S. et al. Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice. Proc. Natl. Acad. Sci. USA 117(40), 24964–24973 (2020).
doi: 10.1073/pnas.2006905117 pubmed: 32958663 pmcid: 7547222
Nourollahpour Shiadeh, M. et al. Human infectious diseases and risk of preeclampsia: an updated review of the literature. Infection. 45(5), 589–600 (2017).
doi: 10.1007/s15010-017-1031-2 pubmed: 28577241
Racicot, K. & Mor, G. Risks associated with viral infections during pregnancy. J. Clin. Invest. 127(5), 1591–1599 (2017).
doi: 10.1172/JCI87490 pubmed: 28459427 pmcid: 5409792
Caserta, M. T., Hall, C. B., Schnabel, K., Lofthus, G. & McDermott, M. P. Human herpesvirus (HHV)-6 and HHV-7 infections in pregnant women. J. Infect. Dis. 196(9), 1296–1303 (2007).
pubmed: 17922393
Aubin, J. T. et al. Intrauterine transmission of human herpesvirus 6. Lancet. 340(8817), 482–483 (1992).
doi: 10.1016/0140-6736(92)91801-E pubmed: 1354806
Gibson, C. S. et al. Fetal exposure to herpesviruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG. 115(4), 492–500 (2008).
doi: 10.1111/j.1471-0528.2007.01653.x pubmed: 18271886 pmcid: 7161814
Gaccioli, F. et al. Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia. Nat. Microbiol. 5(7), 901–908 (2020).
doi: 10.1038/s41564-020-0711-3 pubmed: 32367053 pmcid: 7610361
Komaroff, A. L., Rizzo, R. & Ecker, J. L. Human herpesviruses 6A and 6B in reproductive diseases. Front. Immunol. 12, 648945 (2021).
doi: 10.3389/fimmu.2021.648945 pubmed: 33841432 pmcid: 8027340
Marci, R. et al. Presence of HHV-6A in endometrial epithelial cells from women with primary unexplained infertility. PLoS One. 11(7), e0158304 (2016).
doi: 10.1371/journal.pone.0158304 pubmed: 27367597 pmcid: 4930213
Miura, H. et al. Inherited chromosomally integrated human herpesvirus 6 is a risk factor for spontaneous abortion. J. Infect. Dis. 223(10), 1717–1723 (2021).
doi: 10.1093/infdis/jiaa606 pubmed: 32984876
Tanaka-Taya, K. et al. Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J. Med. Virol. 73(3), 465–473 (2004).
doi: 10.1002/jmv.20113 pubmed: 15170644
Arbuckle, J. H. et al. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc. Natl. Acad. Sci. USA 107(12), 5563–5568 (2010).
doi: 10.1073/pnas.0913586107 pubmed: 20212114 pmcid: 2851814
Jääskeläinen, T. et al. Cohort profile: The Finnish genetics of pre-eclampsia consortium (FINNPEC). BMJ Open. 6(11), e013148 (2016).
doi: 10.1136/bmjopen-2016-013148 pubmed: 28067621 pmcid: 5129003
ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 77(1), 67–75 (2002).
Pihkala, J. et al. Characteristic of recent fetal growth curves in Finland. Duodecim 105, 1540–1546 (1989).
pubmed: 2680445
Acharya, G., Wilsgaard, T., Berntsen, G. K., Maltau, J. M. & Kiserud, T. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am. J. Obstet. Gynecol. 192(3), 937–944 (2005).
doi: 10.1016/j.ajog.2004.09.019 pubmed: 15746695
Pyöriä, L., Jokinen, M., Toppinen, M., Salminen, H., Vuorinen, T., Hukkanen, V., et al. HERQ-9 is a new multiplex PCR for differentiation and quantification of all nine human herpesviruses. mSphere. 5(3) (2020).
Borodulin, K. et al. Cohort profile: The national FINRISK study. Int. J. Epidemiol. 47(3), 696–696i (2018).
doi: 10.1093/ije/dyx239 pubmed: 29165699
Ganel, L. et al. Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences. Hum. Genomics. 15(1), 34 (2021).
doi: 10.1186/s40246-021-00335-2 pubmed: 34099068 pmcid: 8185936
Kojima, S., Kamada, A. J. & Parrish, N. F. Virus-derived variation in diverse human genomes. PLoS Genet. 17(4), e1009324 (2021).
doi: 10.1371/journal.pgen.1009324 pubmed: 33901175 pmcid: 8101998
Fairley, S., Lowy-Gallego, E., Perry, E. & Flicek, P. The International Genome Sample Resource (IGSR) collection of open human genomic variation resources. Nucleic Acids Res. 48(D1), D941–D947 (2020).
doi: 10.1093/nar/gkz836 pubmed: 31584097
Pellett, P. E. et al. Chromosomally integrated human herpesvirus 6: Questions and answers. Rev. Med. Virol. 22(3), 144–155 (2012).
doi: 10.1002/rmv.715 pubmed: 22052666
Adams, O., Krempe, C., Kogler, G., Wernet, P. & Scheid, A. Congenital infections with human herpesvirus 6. J. Infect. Dis. 178(2), 544–546 (1998).
doi: 10.1086/517470 pubmed: 9697740
Hall, C. B. et al. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J. Pediatr. 145(4), 472–477 (2004).
doi: 10.1016/j.jpeds.2004.06.017 pubmed: 15480369
Norton, R. A. et al. Detection of human herpesvirus 6 by reverse transcription-PCR. J Clin Microbiol. 37(11), 3672–3675 (1999).
doi: 10.1128/JCM.37.11.3672-3675.1999 pubmed: 10523572 pmcid: 85721
Braun, D. K., Dominguez, G. & Pellett, P. E. Human herpesvirus 6. Clin. Microbiol. Rev. 10(3), 521–567 (1997).
doi: 10.1128/CMR.10.3.521 pubmed: 9227865 pmcid: 172933
Pyöriä, L. et al. Unmasking the tissue-resident eukaryotic DNA virome in humans. Nucleic Acids Res. 51(7), 3223–3239 (2023).
doi: 10.1093/nar/gkad199 pubmed: 36951096 pmcid: 10123123
De Bolle, L., Naesens, L. & De Clercq, E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 18(1), 217–245 (2005).
doi: 10.1128/CMR.18.1.217-245.2005 pubmed: 15653828 pmcid: 544175
Csoma, E. et al. Human herpesvirus 6 variant a infects human term syncytiotrophoblasts in vitro and induces replication of human immunodeficiency virus type 1 in dually infected cells. J. Med. Virol. 67(1), 67–87 (2002).
doi: 10.1002/jmv.2194 pubmed: 11920820
Bortolotti, D. et al. HHV-6A infection of endometrial epithelial cells affects miRNA expression and trophoblast cell attachment. Reprod. Sci. 27(3), 779–786 (2020).
doi: 10.1007/s43032-019-00102-8 pubmed: 32046402
Alshareef, S. A., Eltom, A. M., Nasr, A. M., Hamdan, H. Z. & Adam, I. Rubella, herpes simplex virus type 2 and preeclampsia. Virol. J. 14(1), 142 (2017).
doi: 10.1186/s12985-017-0813-6 pubmed: 28747200 pmcid: 5530498
Geraili, Z. et al. Cytomegalovirus infection and risk of preeclampsia: A meta-analysis of observational studies. Caspian J. Intern. Med. 9(3), 211–219 (2018).
pubmed: 30197764 pmcid: 6121334
Hall, C. B. et al. Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus. J. Infect. Dis. 201(4), 505–507 (2010).
doi: 10.1086/650495 pubmed: 20088693
Leong, H. N. et al. The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J. Med. Virol. 79(1), 45–51 (2007).
doi: 10.1002/jmv.20760 pubmed: 17133548

Auteurs

Inka Häkkinen (I)

Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.

Gamze Yazgeldi Gunaydin (G)

Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.

Lari Pyöriä (L)

Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Shohei Kojima (S)

Genome Immunobiology RIKEN Hakubi Research Team, RIKEN Center for Integrative Medical Sciences and RIKEN Cluster for Pioneering Research, Yokohama, Japan.

Nicholas Parrish (N)

Genome Immunobiology RIKEN Hakubi Research Team, RIKEN Center for Integrative Medical Sciences and RIKEN Cluster for Pioneering Research, Yokohama, Japan.

Maria F Perdomo (MF)

Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Juho Wedenoja (J)

Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Klaus Hedman (K)

Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Seppo Heinonen (S)

Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Eero Kajantie (E)

Public Health Promotion Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.
PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.

Hannele Laivuori (H)

Department of Obstetrics and Gynecology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
Faculty of Medicine and Health Technology, Center for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland.
Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Juha Kere (J)

Folkhälsan Research Center, Helsinki, Finland.
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.

Shintaro Katayama (S)

Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.

Satu Wedenoja (S)

Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. satu.wedenoja@helsinki.fi.
Information Services Department, Finnish Institute for Health and Welfare, Helsinki, Finland. satu.wedenoja@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH